Cortney Galasso's Colleagues at QED Therapeutics
Cortney Galasso's Contact Details
HQ
650-231-4088
650-231-4088
Location
Denver,Colorado,United States
Denver,Colorado,United States
Company
QED Therapeutics
QED Therapeutics
Cortney Galasso's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Cortney Galasso
Cortney Galasso currently works for QED Therapeutics.
Cortney Galasso's role at QED Therapeutics is Clinical Trial Manager.
Cortney Galasso's email address is ***@qedtx.com. To view Cortney Galasso's full email address, please signup to ConnectPlex.
Cortney Galasso works in the Research industry.
Cortney Galasso's colleagues at QED Therapeutics are Scott Collins, Miki Yamamoto, Mike Monteith, Yvonne Stone, Deborah Mortensen, Greg Troupe, Brian Boyles and others.
Cortney Galasso's phone number is 650-231-4088